| Patents for C07D 333 - Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom (32,883) |
|---|
| 08/16/2007 | CA2641307A1 Niacin receptor agonists, compositions containing such compounds and methods of treatment |
| 08/16/2007 | CA2637771A1 Anthranilamide/2-amino-heteroarene carboxamide derivatives |
| 08/15/2007 | EP1818326A1 Nitrogen-containing heterocyclic compounds and pharmaceutical composition containing the compounds |
| 08/15/2007 | EP1818325A2 3,4-DI-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands |
| 08/15/2007 | EP1817287A1 Aromatic ether derivatives useful as thrombin inhibitors |
| 08/15/2007 | EP1817282A1 Phenoxyacetic acid derivatives useful for treating respiratory diseases |
| 08/15/2007 | EP1523533B1 Luminescent compositions |
| 08/15/2007 | EP1385825B1 Substituted 2-pyridine-cyclohexane-1,4-diamine derivatives |
| 08/15/2007 | CN1331862C Di-aryl acid derivatives as PPAR receptor ligands |
| 08/15/2007 | CN1331848C Tricyclic steroid hormone nuclear receptor modulators |
| 08/15/2007 | CN101018774A Modulators of alpha7 nicotinic acetylcholine receptors and therapeutic uses thereof |
| 08/15/2007 | CN101018761A Methods and compositions for modulating sphingosine-1-phosphate(S1P) receptor activity |
| 08/15/2007 | CN101016306A Synthesis of middle position-tetraphenyldiphenanthrene disulphoporphyrin derivative and application thereof |
| 08/15/2007 | CN101016296A Muscarinic agonists |
| 08/15/2007 | CN101016254A Chemical synthesis method for nitriles substance |
| 08/14/2007 | US7256219 Multifluoro-substituted chalcones and analogs as activators of caspases and inducers of apoptosis and the use thereof |
| 08/14/2007 | US7256206 1-[4-(3-Amino-4-hydroxy-3-hydroxymethyl-butyl)-phenyl]-ethanone-O-biphenyl-4-ylmethyl-oxime, used as modulators of lipid activated G-protein coupled receptors specific for sphingosine-1-phosphate; prevention of autoimmune diseases or as angiogenesis inhibitors |
| 08/14/2007 | US7256204 6-(4-biphenylyl)methoxy-2-(2-(N,N-dimethylamino)ethyl)tetralin for example; inhibiting amyloid-beta protein production; for neurodegenerative diseases such as Alzheimer's disease |
| 08/14/2007 | US7256158 Animal husbandry; veterinary medicine |
| 08/14/2007 | CA2271607C Process for stabilizing cyanohydrins |
| 08/14/2007 | CA2213714C Phenyl-substituted alkenylcarboxylic acid guanidides, process for their preparation, their use as a medicament or diagnostic, and medicament containing them |
| 08/14/2007 | CA2206758C Ortho-substituted benzoylguanidines, process for their preparation, their use as a medicament or diagnostic, and medicament containing them |
| 08/09/2007 | WO2007089669A2 Processes for the preparation of compounds which modulate cell proliferation |
| 08/09/2007 | WO2007087906A1 Fungicide n-cycloalkyl-benzyl-amide derivatives |
| 08/09/2007 | WO2007087684A1 Substituted benzofurans, benzothiophenes, benzoselenophenes and indoles and their use as tubulin polymerisation inhibitors |
| 08/09/2007 | US20070185191 Hydrazide derivatives as prostaglandin receptors modulators |
| 08/09/2007 | US20070185109 Idene derivatives and process for the preparation thereof |
| 08/09/2007 | US20070185056 2-(2-Phenyl-2,3-dihydro-1H-inden-2-yl)-N-1,3-thiazol-2-ylacetamide; activating proteins-1 (AP-1); transactivation antagonists; side effects reduction; obesity, antidiabetic agents; non-steroidal antiinflammatory agents; immunology; osteoporosis; glaucoma; Addison's disease |
| 08/09/2007 | US20070184384 Novel sulfonium compound, photosensitive composition containing the compound and pattern-forming method using the photosensitive composition |
| 08/09/2007 | CA2640678A1 Substituted benzofurans, benzothiophenes, benzoselenophenes and indoles and their use as tubulin polymerisation inhibitors |
| 08/09/2007 | CA2632870A1 Fungicide n-cycloalkyl-benzyl-amide derivatives |
| 08/08/2007 | EP1816519A1 Novel sulfonium compound, photosensitive composition containing the compound and pattern-forming method using the photosensitive composition |
| 08/08/2007 | EP1816114A1 Pyrene compound and light emitting transistor device utilizing the same |
| 08/08/2007 | EP1815860A2 Phosphate transport inhibitors |
| 08/08/2007 | EP1814876A2 Heterocyclic dye compounds for in vivo imaging and diagnosis of alzheimer's disease |
| 08/08/2007 | EP1814872A1 Substituted [(phenylethanoyl)amino] benzamides and the use thereof in the treatment of inflammatory and cardio-vascular diseases |
| 08/08/2007 | EP1814871A2 Compounds that modulate ppary type receptors, and use thereof in cosmetic or pharmaceutical compositions |
| 08/08/2007 | EP1814869A2 Substituted amino acids as protein tyrosine phosphatase inhibitors |
| 08/08/2007 | EP1814850A1 New histone deacetylases inhibitors |
| 08/08/2007 | EP1814848A1 2,3,4-substituted-cyclopentanones as therapeutic agents |
| 08/08/2007 | EP1277736B1 Novel bicyclic compounds |
| 08/08/2007 | EP0980867B1 Ketone derivatives and medicinal use thereof |
| 08/08/2007 | CN1330632C 2,5-substituted benzoluslfonylureas and thioureas, methods for production thereof, use thereof and pharamceutical preparations containing the same |
| 08/08/2007 | CN1330307C Indole, azaindole and related heterocyclic amidopiperazine derivatives |
| 08/08/2007 | CN1330290C Novel skin lightening agents, compositions and methods |
| 08/08/2007 | CN101014589A Heterocyclyls as selective melanin concentrating hormone receptor antagonists for the treatment of obesity and related disorders |
| 08/08/2007 | CN101012220A Method of preparing N-methyl-3-hydroxy-3-(2-thiophene)propylamine |
| 08/08/2007 | CN101012219A Method of preparing dulouxetine |
| 08/08/2007 | CN101012187A Chiral diene ligand, synthesis method and its application in asymmetric reaction |
| 08/08/2007 | CN101012184A Fluorine-containing cyclopropane and synthetic method thereof |
| 08/07/2007 | US7253297 Astaxanthin esters |
| 08/07/2007 | US7253292 Synthesis of cyclopentadiene derivatives |
| 08/07/2007 | US7253211 (R)-chiral halogenated substituted fused heterocyclic amino compounds useful for inhibiting cholesterol ester transfer protein activity |
| 08/07/2007 | US7253173 E.g., Methyl 3-[(4-[(diethylamino)carbonyl]phenyl)(4-benzyl-piperazin-1-yl)methyl]phenylcarbamate and Methyl 3-{(S)-{4-[(diethylamino)carbonyl]phenyl}[4-(1,3-thiazol-4-ylmethyl)piperazin-1-yl]methyl}phenylcarbamate |
| 08/07/2007 | US7253172 Enzyme inhibitor for treating a non-insulin dependent diabetes mellitus; 3-Amino-4-(3,4-difluorophenyl)butanoyl]-4-[2-({3-[(methylsulfonyl)amino]-phenyl}-amino)-2-oxoethyl]piperazin-2-yl}acetic acid |
| 08/07/2007 | US7253171 Antiinflammatory agents; immunology diseases; multiple sclerosis; antihistamines; antidiabetic agents; vision defects; antiarthritic agents; skin disorders; antitumor agents |
| 08/07/2007 | US7253157 Containing a diazacycloalkane ring, especially a 1,4-diazepane ring, e.g., N-p-((4-(alpha-phenylmethoxycarbonylmethyl)-1,4-diazepan-1-yl)phenyl)-o-biphenylcarboxamide, for the treatment of hyperlipidemia, obesity and type II diabetes. |
| 08/07/2007 | CA2190256C Process for preparing aromatic or heteroaromatic sulfonyl halides |
| 08/02/2007 | WO2007086948A1 Dnt-fumarate and methods of preparation thereof |
| 08/02/2007 | WO2007063702A3 Iminopropene compound and use thereof |
| 08/02/2007 | WO2007060220A3 Cyanobenzene compounds for combating animal pests |
| 08/02/2007 | US20070179297 Chemical compounds |
| 08/02/2007 | US20070179183 N-(2-phenylethyl)sulfamide derivatives as integrin alpha4 antagonists |
| 08/02/2007 | US20070179180 Novel m3 muscarinic acetylcholine receptor antagonists |
| 08/02/2007 | US20070179154 Coumarin derivatives, process for their production and use thereof |
| 08/02/2007 | US20070179143 Tricyclic derivatives or pharmaceutically acceptable salts thereof, their preparations and pharmaceutical compositions containing them |
| 08/02/2007 | US20070179142 Substituted cycloalkylcarboxamides: 1-((1-(4-Chlorophenyl)cyclopropyl)carbonyl)pyrrolidin-3-ol and 1-Acetyl-4-(4-{1-[(3-phenylpyrrolidin-1-yl)carbonyl]cyclopropyl}phenyl)piperazine; 11- beta hydroxyl steroid dehydrogenase type 1 inhibitors; mineralcorticoid receptor antagonists; antidiabetic agents |
| 08/02/2007 | US20070179139 Methyl 4-{[(2-{4-[(4-bromophenoxy)methyl]-2,5-dimethyl-3-thienyl}ethyl)(5-ethoxy-5-oxopentyl)amino]methyl}benzoate, for example; treatment of cardiovascular and other diseases |
| 08/02/2007 | US20070176164 -Conjugated aromatic ring-containing compound and organic electroluminescent device |
| 08/01/2007 | EP1813621A1 Ruthenium complex and process for producing tert-alkyl alcohol therewith |
| 08/01/2007 | EP1813618A1 Method of obtaining derivatives of 4-(n-alkylamine)-5,6-dihydro-4h-thieno-[2,3-b]-thiopyran |
| 08/01/2007 | EP1813607A2 Tetraaza- or N2S2- complexants, and their use in radiodiagnostics or radiotherapy |
| 08/01/2007 | EP1812387A1 2,3,4-substituted cyclopentanones as therapeutic agents |
| 08/01/2007 | EP1812383A1 Glycogen phosphorylase inhibitor compounds and pharmaceutical compositions thereof |
| 08/01/2007 | EP1461038B1 Arylsulfonamide derivatives for use as ccr3 antagonists in the treatment of inflammatory and immunological disorders |
| 08/01/2007 | EP1377542B1 Hiv protease inhibitors based on amino acid derivatives |
| 08/01/2007 | EP1373194B1 BENZAMIDE INHIBITORS OF FACTOR Xa |
| 08/01/2007 | CN1329391C Organic photochromic diaryl ethylene compound and its preparation process and application |
| 08/01/2007 | CN101010312A Quaternary salt CCR2 antagonists |
| 08/01/2007 | CN101010276A Novel cyclohexane derivative, prodrug thereof and salt thereof, and therapeutic agent containing the same for diabetes |
| 08/01/2007 | CN101007825A Ferrocenyl imidazoliny palladium compound, its preparation method and its uses in catalytic synthesis of coupling product |
| 08/01/2007 | CN101007796A Quinary-heterocyclic compound, its preparation method and medical uses |
| 08/01/2007 | CN101007281A Novel preparation method of amorphous alloy catalyst |
| 07/31/2007 | USRE39754 Benzamide derivatives and pharmaceutical compositions containing same |
| 07/31/2007 | US7250525 Stilbene derivatives and their use for binding and imaging amyloid plaques |
| 07/31/2007 | US7250430 Administering N-benzoyl- derivatives, e.g., N-[2,4-dichlorobenzoyl]-5-bromothiophene-2-sulfonamide sodium salt, to treat metastatic soft tissue sarcoma, non-small cell lung cancer, melanoma, ovarian cancer, breast cancer, leukemia, lymphoma, renal cancer, prostate cancer, and multiple myeloma |
| 07/31/2007 | US7250415 1,1-Disubstitutedcycloalkyl-, glycinamidyl-, sulfonyl-amidino-, and tetrahydropyrimidinyl-containing diaminoalkyl, β-aminoacids, α-aminoacids and derivatives thereof as factor Xa inhibitors |
| 07/26/2007 | WO2007084194A1 Dnt-benzenesulfonate and methods of preparation thereof |
| 07/26/2007 | WO2007084193A1 Dnt-succinate and methods of preparation thereof |
| 07/26/2007 | WO2007083689A1 Plasminogen activator inhibitor-1 inhibitor |
| 07/26/2007 | WO2007082840A1 Cyclohexyl sulfonamide derivatives having h3 receptor activity |
| 07/26/2007 | WO2007056087A8 Prostaglandins and analogues as agents for lowering intraocular pressure |
| 07/26/2007 | WO2006065706A9 N-biaryl and n-arylheteroaryl 2-substituted piperazine derivatives as modulators of the 5ht2c receptor useful for the treatment of disorders related thereto |
| 07/26/2007 | WO2006056462A9 Azine compounds for combating animal pests |
| 07/26/2007 | WO2005108844A3 Threaded connection for oil field applications |
| 07/26/2007 | US20070173548 Malonamic acids and derivatives thereof as thyroid receptor ligands |
| 07/26/2007 | US20070173541 DNT-succinate and methods of preparation thereof |
| 07/26/2007 | US20070173540 DNT-benzenesulfonate and methods of preparation thereof |
| 07/26/2007 | US20070173502 Novel urea derivatives, method for preparing same, use thereof as medicines, pharmaceutical compositions and novel use |
| 07/26/2007 | US20070173498 Melanin concentrating hormone antagonist |